Valuation: Elanco Animal Health Incorporated

Capitalization 6.14B 5.86B 5.43B 4.82B 8.68B 521B 9.64B 67.45B 24.98B 214B 23.07B 22.55B 936B P/E ratio 2024 *
19.6x
P/E ratio 2025 * 128x
Enterprise value 10.17B 9.7B 8.99B 7.97B 14.38B 862B 15.97B 112B 41.35B 354B 38.19B 37.34B 1,550B EV / Sales 2024 *
2.29x
EV / Sales 2025 * 2.18x
Free-Float
-
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.41%
1 week+3.31%
Current month-4.20%
1 month-11.32%
3 months-12.60%
6 months-31.04%
Current year-15.07%
More quotes
1 week
12.04
Extreme 12.04
13.05
1 month
12.04
Extreme 12.04
14.71
Current year
11.40
Extreme 11.4
18.80
1 year
11.40
Extreme 11.4
18.80
3 years
7.88
Extreme 7.88
29.66
5 years
7.88
Extreme 7.88
37.49
10 years
7.88
Extreme 7.88
37.61
More quotes
Director TitleAgeSince
Chief Executive Officer 56 2018-06-30
Director of Finance/CFO 52 2018-12-13
Chief Tech/Sci/R&D Officer - -
Manager TitleAgeSince
Director/Board Member 56 2018-06-30
Chairman 78 2018-04-30
Director/Board Member 70 2018-08-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.41%+3.31%-0.43%-54.38%6.14B
+0.71%+1.55%-6.03%-23.38%79.73B
+1.36%+1.45%+45.90%-8.11%4.09B
-1.52%+3.01%+8.70%-26.64%2.9B
+0.37%-3.87%+53.95%-38.05%1.94B
+1.70%-1.78%+21.38%-10.18%1.27B
+2.22%+1.66%-34.84%-36.57%1.02B
-0.26%+1.43%-15.62%-40.78%1B
+1.70%-2.39%-14.43%-41.23%950M
+2.94%+0.30%+116.04%+22.86%936M
Average +1.06%-0.19%+17.46%-25.65% 10B
Weighted average by Cap. +0.76%-0.08%-0.94%-24.91%
See all sector performances

Financials

2024 *2025 *
Net sales 4.43B 4.23B 3.92B 3.48B 6.27B 376B 6.96B 48.7B 18.03B 155B 16.65B 16.29B 676B 4.55B 4.34B 4.03B 3.57B 6.44B 386B 7.15B 50.01B 18.52B 159B 17.1B 16.72B 694B
Net income 320M 305M 283M 251M 452M 27.1B 502M 3.51B 1.3B 11.14B 1.2B 1.17B 48.73B 16.16M 15.41M 14.29M 12.68M 22.85M 1.37B 25.38M 178M 65.74M 563M 60.71M 59.36M 2.46B
Net Debt 4.03B 3.84B 3.56B 3.16B 5.69B 341B 6.32B 44.23B 16.38B 140B 15.12B 14.79B 614B 3.8B 3.62B 3.36B 2.98B 5.37B 322B 5.96B 41.7B 15.44B 132B 14.26B 13.95B 579B
More financial data * Estimated data
Logo Elanco Animal Health Incorporated
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Employees
9,550
More about the company
Date Price Change Volume
24-12-11 12.66 $ +1.89% 1,419,963
24-12-10 12.42 $ -3.57% 5,288,941
24-12-09 12.88 $ +3.04% 4,276,903
24-12-06 12.50 $ +3.14% 4,585,191
24-12-05 12.12 $ -1.06% 6,369,170

Delayed Quote Nyse, December 11, 2024 at 02:35 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
surperformance-ratings-light-chart ELANCO-ANIMAL-HEALTH-INCOMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
12.42USD
Average target price
17.50USD
Spread / Average Target
+40.90%
Consensus

Quarterly revenue - Rate of surprise